← Evidence map

ArticleLeukemia2013

Safety and efficacy of CYT387, a JAK1 and JAK2 inhibitor, in myelofibrosis.

A Pardanani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

113 papers cite itlatest 60 shown

2013
…
2014
2015
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23459451